To determine whether the NSCLC-specific CD8+ T cell clones isolated in vitro might have played any role in the spontaneous anti-tumor response in vivo, we investigated whether the molecular fingerprints of the NSCLC-specific TCR clonotypes identified in this study were present at the tumor site. This evidence concerns the gene CD8A and neoplasm.